CLINICAL RESEARCH
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease
Molly Sachdev, MD, MPH*,*,
Jie Lena Sun, MS*,
Anastasios A. Tsiatis, PhD*,
Charlotte L. Nelson, MS*,
Daniel B. Mark, MD, MPH* and
James G. Jollis, MD*
* Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA
Manuscript received October 21, 2002;
revised manuscript received September 22, 2003,
accepted October 7, 2003.
* Reprint requests and correspondence: Dr. Molly Sachdev, Duke University, Internal Medicine, 129 Forest Oaks, Durham, North Carolina 27705, USA. mollysachdev{at}yahoo.com
OBJECTIVES: To identify the prevalent and prognostically important coexisting illnesses among single coronary artery disease (CAD) patients.
BACKGROUND: As the population ages, physicians are increasingly required to make decisions concerning patients with multiple co-existing illnesses (comorbidity). Many trials of CAD therapy have excluded patients with significant comorbidity, such that there are limited data to guide the management of those patients.
METHODS: To consider the long-term prognostic importance of comorbid illness, we examined a cohort of 1,471 patients with CAD who underwent cardiac catheterization between 1985 and 1989 and were followed up through 2000 in the Duke Databank for Cardiovascular Diseases. Weights were assigned to individual diseases according to their prognostic significance in Cox proportional hazards models, thus creating a new CAD-specific index. The new index was compared with the widely used Charlson index, according to prevalence of conditions, individual and overall associations with survival, and agreement.
RESULTS: The Charlson index and the CAD-specific index were highly associated with long-term survival and almost equivalent to left ventricular ejection fraction. When considering the components of the Charlson index, diabetes, renal insufficiency, chronic obstructive pulmonary disease, and peripheral vascular disease had greater prognostic significance among CAD patients, whereas peptic ulcer disease, connective tissue disease, and lymphoma were less significant. Hemiplegia, leukemia, lymphoma, severe liver disease, and acquired immunodeficiency syndrome were rarely identified among patients undergoing coronary angiography.
CONCLUSIONS: Comorbid disease is strongly associated with long-term survival in patients with CAD. These data suggest co-existing illnesses should be measured and considered in clinical trials, disease registries, quality comparisons, and counseling of individual patients.
|
Abbreviations and Acronyms
| | AIDS | = acquired immunodeficiency syndrome | | CAD | = coronary artery disease | | CHF | = congestive heart failure | | LVEF | = left ventricular ejection fraction | | MI | = myocardial infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Schmidt, J. B. Jacobsen, T. L. Lash, H. E. Botker, and H. T. Sorensen
25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study
BMJ,
January 25, 2012;
344(jan25_2):
e356 - e356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ekerstad, E. Swahn, M. Janzon, J. Alfredsson, R. Lofmark, M. Lindenberger, and P. Carlsson
Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non-ST-Segment Elevation Myocardial Infarction
Circulation,
November 29, 2011;
124(22):
2397 - 2404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sanchez, M. T. Vidan, J. A. Serra, F. Fernandez-Aviles, and H. Bueno
Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases
Heart,
October 1, 2011;
97(19):
1602 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Singh, D. R. Holmes, R. J. Lennon, and C. S. Rihal
Development and Validation of Risk Adjustment Models for Long-Term Mortality and Myocardial Infarction Following Percutaneous Coronary Interventions
Circ Cardiovasc Interv,
October 1, 2010;
3(5):
423 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lauck, J. L. Johnson, and P. A. Ratner
Self-Care Behaviour and Factors Associated with Patient Outcomes Following Same-Day Discharge Percutaneous Coronary Intervention
European Journal of Cardiovascular Nursing,
August 1, 2009;
8(3):
190 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Putt, J. A. Long, C. Montagnet, J. H. Silber, V. W. Chang, Kaijun Liao, J. S. Schwartz, C. E. Pollack, Y.-N. Wong, and K. Armstrong
Racial Differences in the Impact of Comorbidities on Survival Among Elderly Men With Prostate Cancer
Med Care Res Rev,
August 1, 2009;
66(4):
409 - 435.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Chan, J. L. Sun, L. K. Newby, L. K. Shaw, M. Lin, E. D. Peterson, R. M. Califf, D. F. Kong, and M. T. Roe
Long-Term Mortality of Patients Undergoing Cardiac Catheterization for ST-Elevation and Non-ST-Elevation Myocardial Infarction
Circulation,
June 23, 2009;
119(24):
3110 - 3117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Galal, Y. R. B. M. van Gestel, S. E. Hoeks, D. D. Sin, T. A. Winkel, J. J. Bax, H. Verhagen, A. M. M. Awara, J. Klein, R. T. van Domburg, et al.
The Obesity Paradox in Patients With Peripheral Arterial Disease
Chest,
November 1, 2008;
134(5):
925 - 930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Singh, C S Rihal, V L Roger, R J Lennon, J Spertus, A Jahangir, and D R Holmes Jr
Comorbid conditions and outcomes after percutaneous coronary intervention
Heart,
November 1, 2008;
94(11):
1424 - 1428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Newman, R. M. Boudreau, B. L. Naydeck, L. F. Fried, and T. B. Harris
A Physiologic Index of Comorbidity: Relationship to Mortality and Disability
J Gerontol A Biol Sci Med Sci,
June 1, 2008;
63(6):
603 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Sorror, S. Giralt, B. M. Sandmaier, M. De Lima, M. Shahjahan, D. G. Maloney, H. J. Deeg, F. R. Appelbaum, B. Storer, and R. Storb
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Blood,
December 15, 2007;
110(13):
4606 - 4613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Halanych, M. M. Safford, W. C. Keys, S. D. Person, J. M. Shikany, Y.-I. Kim, R. M. Centor, and J. J. Allison
Burden of Comorbid Medical Conditions and Quality of Diabetes Care
Diabetes Care,
December 1, 2007;
30(12):
2999 - 3004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Schneider, Y. Zhu, T. Coleman, and C. F. Semenkovich
Macrophage 3 Integrin Suppresses Hyperlipidemia-Induced Inflammation by Modulating TNF{alpha} Expression
Arterioscler Thromb Vasc Biol,
December 1, 2007;
27(12):
2699 - 2706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hemingway, J. Vahtera, M. Virtanen, J. Pentti, and M. Kivimaki
Outcome of stable angina in a working population: the burden of sickness absence
European Journal of Cardiovascular Prevention & Rehabilitation,
June 1, 2007;
14(3):
373 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bindra, C. Berry, J. Rogers, N. Stewart, M. Watts, J. Christie, S.M. Cobbe, and H. Eteiba
Abnormal haemoglobin levels in acute coronary syndromes.
QJM,
December 1, 2006;
99(12):
851 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. El-Sherif, W. E. Gooding, R. Santos, B. Pettiford, P. F. Ferson, H. C. Fernando, S. J. Urda, J. D. Luketich, and R. J. Landreneau
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non-Small Cell Lung Cancer: A 13-Year Analysis
Ann. Thorac. Surg.,
August 1, 2006;
82(2):
408 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Mehta, E. Honeycutt, E. D. Peterson, C. B. Granger, A. R. Halabi, L. K. Shaw, P. K. Smith, R. M. Califf, R. A. Harrington, and M. H. Sketch Jr
Impact of Internal Mammary Artery Conduit on Long-term Outcomes After Percutaneous Intervention of Saphenous Vein Graft
Circulation,
July 4, 2006;
114(1_suppl):
I-396 - I-401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3_Suppl_S):
S21 - S29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A Daly, B. De Stavola, J. L L. Sendon, L. Tavazzi, E. Boersma, F. Clemens, N. Danchin, F. Delahaye, A. Gitt, D. Julian, et al.
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study
BMJ,
February 4, 2006;
332(7536):
262 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Sorror, M. B. Maris, R. Storb, F. Baron, B. M. Sandmaier, D. G. Maloney, and B. Storer
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
Blood,
October 15, 2005;
106(8):
2912 - 2919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
 |
|
|